The debate around the patentability of nature-based claims, in the UK and worldwide, is currently under the spotlight following huge advances in understanding our microbial ecology and the consequential rise in companies looking to commercialise inventions in this area. Where does this leave life sciences companies looking to protect emerging microbiome technologies?
The debate around the patentability of nature-based claims, in the UK and worldwide, is currently under the spotlight following huge advances in understanding our microbial ecology and the consequential rise in companies looking to commercialise inventions in this area. Where does this leave life sciences companies looking to protect emerging microbiome technologies? We explore these issues in this recent post on our Life Sciences blog, 'Legal Cerebrum', here.